Collector
Giriş Yap
Pharma stocks are showing strength. Charts predict this name could break out next | Collector
CNBC

Pharma stocks are showing strength. Charts predict this name could break out next

Pharmaceutical stocks have recently separated themselves from the broader market, and the group has become a source of leadership within healthcare.

Go to News Site
Google Play Google Play App Store App Store
An inflation storm is brewing in the Pacific Ocean
MarketWatch
An inflation storm is brewing in the Pacific Ocean — and your portfolio isn’t ready
 Idris And Sabrina Elba, Chance The Rapper, Stress
Black Enterprise
Idris And Sabrina Elba, Chance The Rapper, Stress The Need For Social Change At TIME100 Philanthropy Impact Dinner
 JPMorgan Shops 15% Yield Debt for Oil Driller Boos
Bloomberg Markets
JPMorgan Shops 15% Yield Debt for Oil Driller Boosted by Trump
 Pulte is 'Woefully Under Qualify' To Be Intelligen
Bloomberg Markets
Pulte is 'Woefully Under Qualify' To Be Intelligence Director Says Riggleman
 Investors Fled From Bearish Oil Fund at a Record P
Bloomberg Markets
Investors Fled From Bearish Oil Fund at a Record Pace Last Week
 The best destinations in the world for cheese love
Quartz
The best destinations in the world for cheese lovers
CNBC
CNBC
Apple shares reverse lower after big Siri news. Why we're not bothered
CNBC
Four high-yield savings accounts cut their rates. Where you can still earn 4%
CNBC
We're getting closer to upgrading Honeywell as shares pull back into its breakup
CNBC
Strong earthquake strikes off Cuba's northwest coast
CNBC
Tom Lee's clients are worried SpaceX IPO will mark a market top. He's not
CNBC
SpaceX top? Major IPOs don't typically flag a bull market peak, history shows
CNBC
Silicon Valley’s new buyout playbook is hitting Wall Street
CNBC
Judge blocks Trump's $100,000 H-1B visa fee
CNBC
Chip rebound sparks hedging flurry from traders
CNBC
Airlines find the grass isn't always greener with new engines
CNBC
Convicted FTX founder Sam Bankman-Fried files formal request for Trump pardon
CNBC
Jim Cramer says he can't sell Eli Lilly despite its massive run up. Here's why